| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/28/2011 | US20110182906 Fully human antibody to human tnf-alpha, molecular evolution and use thereof |
| 07/28/2011 | US20110182905 Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same |
| 07/28/2011 | US20110182904 Antibodies to bone morphogenic proteins and receptors therefor and methods for their use |
| 07/28/2011 | US20110182901 Full length large t tumor antigen of merkel cell polyomavirus as a therapeutic target in merkel cell carcinoma |
| 07/28/2011 | US20110182900 Compositions and methods for treating coagulation related disorders |
| 07/28/2011 | US20110182899 Anti-glycoptrotein vi scfv fragment for treatment of thrombosis |
| 07/28/2011 | US20110182897 Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases |
| 07/28/2011 | US20110182896 CLOTTING FACTOR-Fc CHIMERIC PROTEINS TO TREAT HEMOPHILIA |
| 07/28/2011 | US20110182895 Antibody variants |
| 07/28/2011 | US20110182894 Methods of treating diabetes using IL-1beta antibodies |
| 07/28/2011 | US20110182893 Prevention and treatment of amyloidogenic diseases |
| 07/28/2011 | US20110182892 Methods to identify responsive patients |
| 07/28/2011 | US20110182890 Anti-pleiotrophin antibodies and methods of use thereof |
| 07/28/2011 | US20110182886 Compositions and methods for inhibiting tumor progression |
| 07/28/2011 | US20110182884 P-cadherin antibodies |
| 07/28/2011 | US20110182879 Novel human transferase family members and uses thereof |
| 07/28/2011 | US20110182878 Anti-Ricin Antibody |
| 07/28/2011 | US20110182817 Antibody against calcified globule and use of the same |
| 07/28/2011 | US20110182816 ANTIBODY AGAINST OXIDIZED LDL/ß2GPI COMPLEX AND USE OF THE SAME |
| 07/28/2011 | US20110182811 Nucleotide sequence encoding a modulator of nf-kb |
| 07/28/2011 | DE102006041455B4 Verfahren zur Herstellung einer einen stabilisierten funktionellen humanen Einzelketten-Antigen-erkennenden-TCR (scTCR) exprimierenden Zelllinie, damit hergestellt Zelllinie, stabilisierter TAA-spezifischer scTCR, deren Verwendungen und diese enthaltende pharmazeutische Zusammmensetzungen A method for preparing a stabilized functional human single-chain antigen-recognizing TCR (scTCR) expressing cell line, thus established cell line, stabilized TAA-specific scTCR, their uses and pharmaceutical containing them Zusammmensetzungen |
| 07/28/2011 | CA2787783A1 Anti-ilt5 antibodies and ilt5-binding antibody fragments |
| 07/28/2011 | CA2787566A1 Anticoagulant antidotes |
| 07/28/2011 | CA2787479A1 Compositions and methods for treatment of ovarian cancer |
| 07/28/2011 | CA2787074A1 Novel class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type i receptor (igf-1r) |
| 07/28/2011 | CA2786212A1 Cancer stem cell markers and uses thereof |
| 07/28/2011 | CA2785907A1 Ron binding constructs and methods of use thereof |
| 07/28/2011 | CA2785723A1 Inhibitors of vascular endothelial growth factor (vegf) receptors and methods of use thereof |
| 07/28/2011 | CA2785661A1 Polypeptide heterodimers and uses thereof |
| 07/28/2011 | CA2784959A1 Chromatographic method for purifying fc-containing proteins |
| 07/28/2011 | CA2784814A1 Heterodimer binding proteins and uses thereof |
| 07/27/2011 | EP2348135A2 Identification of surface-associated antigenes used for the diagnosis and therapy of tumours |
| 07/27/2011 | EP2348126A2 Production of anti-amyloid beta antibodies |
| 07/27/2011 | EP2348106A1 Chimeric proteins, cells comprising same, and assays using same |
| 07/27/2011 | EP2348052A2 Internalizing human monoclonal antibodies targeting prostate cancer cells in situ |
| 07/27/2011 | EP2348051A2 CD20 antibodies with increased fc receptor binding affinity and effector function |
| 07/27/2011 | EP2348050A1 Anti-glycated CD59 antibodies and uses thereof |
| 07/27/2011 | EP2348048A1 Antagonistic Anti-HTNFSF13B Human Antibodies |
| 07/27/2011 | EP2348045A1 Receptor, use of same and murine antibody |
| 07/27/2011 | EP2348037A1 Method for introducing dota |
| 07/27/2011 | EP2347769A1 Cancer stem cell markers and uses thereof |
| 07/27/2011 | EP2347767A2 Immune regulation based on the targeting of early activation molecules |
| 07/27/2011 | EP2347766A1 Use of TNFalpha antibodies and another drug |
| 07/27/2011 | EP2347038A1 Methods of humanizing and affinity-maturing antibodies |
| 07/27/2011 | EP2347004A1 Reagents and methods for detecting a polymorphic protein |
| 07/27/2011 | EP2346994A2 Non-human mammals for the production of chimeric antibodies |
| 07/27/2011 | EP2346993A1 Efficient expression of truncated human rnaset2 in e.coli |
| 07/27/2011 | EP2346904A1 Methods and agents for the diagnosis and treatment of hepatocellular carcinoma |
| 07/27/2011 | EP2346903A1 Treatment with anti-alpha2 integrin antibodies |
| 07/27/2011 | EP2346902A1 Modulating neuronal plasticity and treatment of neuronal loss by modulating wnt7a or wnt7b modulation |
| 07/27/2011 | EP2346901A1 Antibodies that bind to il-18 and methods of purifying the same |
| 07/27/2011 | EP2346900A1 Methods for purification of single domain antigen binding molecules |
| 07/27/2011 | EP2346899A2 Cell-penetrating, sequence-specific and nucleic acid-hydrolyzing antibody, method for preparing the same and pharmaceutical composition comprising the same |
| 07/27/2011 | EP2346898A2 Antibodies that bind to il-12 and methods of purifying the same |
| 07/27/2011 | EP2346897A2 Viral inactivation during purification of antibodies |
| 07/27/2011 | EP2346529A1 Human m2e peptide immunogens |
| 07/27/2011 | EP1960428B1 Antibodies against amyloid beta with glycosylation in the variable region |
| 07/27/2011 | EP1832654B1 Anti-human soluble fibrin monoclonal antibody and immunological assay method using the antibody |
| 07/27/2011 | EP1776142B1 Il-17 antagonistic antibodies |
| 07/27/2011 | EP1664312B1 Rodent expression systems utilising polyoma virus and epstein barr virus sequences |
| 07/27/2011 | EP1633396B1 Cd20 binding molecules |
| 07/27/2011 | EP1631590B1 Humanized antibodies to interferon alpha receptor-1 (ifnar-1) |
| 07/27/2011 | EP1610678B1 Antibodies for inhibiting the activity of mmp-2 and mmp-9 |
| 07/27/2011 | EP1594543B1 Immunogene adherence inhibitor and method of making and using the same |
| 07/27/2011 | EP1578439B1 Low dose methods for treating disorders in which tnf-alpha activity is detrimental |
| 07/27/2011 | EP1558645B1 Stabilized single domain antibodies in pharmaceutical composition adapted for inhalation |
| 07/27/2011 | EP1534284B1 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders |
| 07/27/2011 | EP1461300B1 Antibodies against monocyte chemotactic proteins |
| 07/27/2011 | EP1434854B1 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 07/27/2011 | EP1125585B1 Treatment of graft-versus-host disease targeting ailim |
| 07/27/2011 | CN102137929A Anti-CDH3 antibodies labeled with radioisotope label and uses thereof |
| 07/27/2011 | CN102137928A Method for cloning avian-derived antibodies |
| 07/27/2011 | CN102137874A Recombinant anti-epidermal growth factor receptor antibody compositions |
| 07/27/2011 | CN102137873A Anti-CD5 antibodies |
| 07/27/2011 | CN102137872A Cross-reactive and bispecific anti-IL 17A/F antibodies |
| 07/27/2011 | CN102137871A Anti-human interleukin-20 antibodies |
| 07/27/2011 | CN102137870A Antibody directed against PcrV |
| 07/27/2011 | CN102137681A Anti-pancreatic cancer antibodies |
| 07/27/2011 | CN102134609A Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 07/27/2011 | CN102134276A Chimeric antibody resisting CTLA-4 (Cytotoxic T Lymphocyte Antigen) |
| 07/27/2011 | CN102134275A 表皮生长因子受体变异体 Epidermal growth factor receptor variant |
| 07/27/2011 | CN102133407A Conjugates of therapeutic or cytotoxic agents and biologically active peptides |
| 07/27/2011 | CN101690813B Concentrated freeze-dried yolk antibody composite preparation for Newcastle disease and preparation process thereof |
| 07/27/2011 | CN101560257B Heavy metal copper monoclonal antibody and preparation method thereof |
| 07/27/2011 | CN101538328B Humanized neutralizing engineered antibody for targeting avian influenza virus H5N1 |
| 07/27/2011 | CN101440130B Variable regions of heavy chain and light chain of antihuman IL-13R alpha 2 monoclonal antibody |
| 07/27/2011 | CN101402674B Functional peptide segment of epididymis protease inhibitors and uses thereof |
| 07/27/2011 | CN101367876B Monoclonal antiidiotypic antibody NP30 single-specificity double-chain antibody of Japanese blood fluke, preparation method and uses thereof |
| 07/27/2011 | CN101062949B Recombinant anti human IgE monoclonal antibody and preparation method and usage thereof |
| 07/27/2011 | CN101010427B Anti-A33 antibody |
| 07/26/2011 | US7985844 Antibody that specifically binds hyaluronan synthase |
| 07/26/2011 | US7985843 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/26/2011 | US7985842 Anti-IGF-I receptor antibody |
| 07/26/2011 | US7985841 Heterodimeric receptor libraries using phagemids |
| 07/26/2011 | US7985840 Polypeptide fusion comprising complementary determining regions for use as tool in immunotherapeutic and/or diagnostics; bioassay |
| 07/26/2011 | US7985834 Compositions and methods for increasing bone mineralization |
| 07/26/2011 | US7985832 Antimicrobial cathelicidin peptides |
| 07/26/2011 | US7985564 Expression systems with sec-system secretion |
| 07/26/2011 | US7985557 Polymeric carriers for immunohistochemistry and in situ hybridization |
| 07/26/2011 | US7985548 Materials and methods directed to asparagine synthetase and asparaginase therapies |